Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT07601347
Recruiting Not applicable

Effect of Immediate Placement and Loading of Compressive Versus Conventional Implants

NCT07601347 · tracked via the Priya Life Science Egypt tracker
Sponsor
Ahmed Nagi Alghandour
Phase
Not applicable
Started
2025-12-01
Last updated
2026-05-22

Condition(s) studied

Other Endosseous Dental Implant Failure

Investigational drug(s) / intervention(s)

Immediate implant placement and loadingImmediate implant placement and loading

Immediate implant placement and loading: 1. Preoperative Cone beam 2. Articaine 4% local anesthesia in two sides 3. Piezoelectric device used around the badly decay tooth 4. Ensuring the preservation of the associated gingiva and papillae. 5. Following the elevation of the flap, atraumatic extraction by using piezoelectric device: A. The teeth will be retrieved without stress. B. The Conventional dental implant will be put directly into the alveolar bone c. Placement of healing abutment in conventional implant and measurement d. Stability measured using AnyCheck or periotest device of both implants and crestal bone level by periodontal probe postoperatively. e. Suturing f. Cone beam xray postoperatively g. Postoperative instructions and medications h. after one week immediate loading by placement of temporary pmma crown

Immediate implant placement and loading: 1. Preoperative Cone beam 2. Articaine 4% local anesthesia in two sides 3. Piezoelectric device used around the badly decay tooth 4. Ensuring the preservation of the associated gingiva and papillae. 5. Following the elevation of the flap, atraumatic extraction by using piezoelectric device: A. The teeth will be retrieved without stress. B. The Compressive dental implant will be put directly into the alveolar bone c. Stability measured using AnyCheck or periotest device of both implants and crestal bone level by periodontal probe postoperatively. d. Suturing e. Cone beam xray postoperatively f. Postoperative instructions and medications g. after one week immediate loading by placement of temporary pmma crown

Study summary

The current study aims to compare immediate placement and loading of compressive versus conventional dental implants after atraumatic extraction regarding the effectiveness, bone resorption and survival of each of them.

Eligibility

Sex
ALL
Min age
20 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Medically free patient * Males and females * Non-smoker patients * Age ranging from 20-40 years * Badly destructed upper premolar teeth that require implants, bone covering 2/3 of the root and of sufficient bone volume. Exclusion Criteria: * Patients with systemic conditions known to affect the periodontal status and healing such as uncontrolled diabetes and osteoporosis * Heavy smokers * Unfavorable position of the tooth or remaining roots * Vitamin D deficiency, * Periapical lesion/ periodontal affection

Primary outcome measure(s)

  • stability — 6 months
    using AnyCheck Device from 1 to 100
  • Pain after the surgery — 6 months
    using visual analogue scale from 1 to 10
  • Crestal Bone resorption and deposition — 6 months
    using cone beam computed tomography .
  • Crestal bone loss — 6 months
    using periodontal probe

Trial sites (1)

FacilityCityRegionStatus
Beni-suef university Banī Suwayf Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07601347 on ClinicalTrials.gov ↗ ← All trials in Egypt